J. Duraj

发表

Salidroside, a Chemopreventive Glycoside, Diminishes Cytotoxic Effect of Cisplatin in Vitro

D. Cholujová, E. Gálová, E. Horváthová, 2018, Basic & clinical pharmacology & toxicology.

Modulation of cisplatin sensitivity in human ovarian carcinoma A2780 and SKOV3 cell lines by sulforaphane.

D. Cholujová, J. Sedlák, E. Horváthová, 2014, Toxicology letters.

Detection of apoptosis in a heterogenous cell population using flow cytometry.

L. Novotný, J. Chovancová, J. Sedlák, 1999, General physiology and biophysics.

Proteasome inhibition leads to altered signaling in the proteome of cisplatin-resistant human ovarian carcinoma cell line.

D. Cholujová, J. Sedlák, L. Hunáková, 2013, Neoplasma.

Sensitisation for cisplatin-induced apoptosis by isothiocyanate E-4IB leads to signalling pathways alterations

P. Kvasnička, J. Kašpárková, J. Jakubikova, 2006, British Journal of Cancer.

Modulation of markers associated with aggressive phenotype in MDA-MB-231 breast carcinoma cells by sulforaphane.

D. Cholujová, J. Sedlák, J. Duraj, 2009, Neoplasma.

MGN-3 arabinoxylan rice bran modulates innate immunity in multiple myeloma patients

J. Jakubikova, D. Cholujová, J. Sedlák, 2013, Cancer Immunology, Immunotherapy.

Isothiocyanate E‐4IB induces MAPK activation, delayed cell cycle transition and apoptosis

J. Jakubikova, J. Sedlák, J. Bodo, 2007, Cell proliferation.

Tyrosine kinase inhibitor-induced differentiation of K-562 cells: alterations of cell cycle and cell surface phenotype.

J. Sedlák, J. Duraj, B. Chorvath, 1994, Cancer letters.

Flavonoid quercetin, but not apigenin or luteolin, induced apoptosis in human myeloid leukemia cells and their resistant variants.

J. Sedlák, J. Bodo, J. Duraj, 2005, Neoplasma.

Characterization of a new murine monoclonal antibody against human DP antigens.

J. Sedlák, V. Hořejší, J. Duraj, 1988, Tissue antigens.

Stimulation of 1-(beta-D-arabinofuranosyl)cytosine (AraC)-induced apoptosis in the multidrug resistant human promyelocytic leukemia cell lines with protein kinase inhibitors.

J. Sedlák, J. Duraj, M. Sulíková, 1996, Neoplasma.

Staurosporine enhanced benzamide riboside-induced apoptosis in human multidrug-resistant promyelocytic leukemia cells (HL-60/VCR) in vitro.

T. Szekeres, L. Novotný, J. Sedlák, 1998, Neoplasma.

The Escherichia coli recA gene increases resistance of the yeast Saccharomyces cerevisiae to ionizing and ultraviolet radiation

V. Vlčková, J. Brozmanová, Ľ. Černáková, 1991, Molecular and General Genetics MGG.

PK11195, an isoquinoline carboxamide ligand of the mitochondrial benzodiazepine receptor, increased drug uptake and facilitated drug-induced apoptosis in human multidrug-resistant leukemia cells in vitro.

J. Jakubikova, J. Sedlák, J. Duraj, 2002, Neoplasma.

Monoclonal antibody directed to MHC class I antigen (Bra23/9): characterization and utilization for study of antigen expression in differentiation of U 937 cell line.

J. Sedlák, J. Duraj, B. Chorvath, 1988, Neoplasma.

Realgar (As4S4) nanoparticles and arsenic trioxide (As2O3) induced autophagy and apoptosis in human melanoma cells in vitro.

T. Lee, D. Cholujová, J. Sedlák, 2014, Neoplasma.

Hemopoietic cell line distribution and immunoprecipitation of cell surface proteins recognized by two newly prepared monoclonal antibodies elicited by a human non-T, non-B leukemia cell line.

J. Sedlák, P. Ujházy, J. Duraj, 1985, Neoplasma.

Monoclonal antibodies to two adhesive cell surface antigens (CD43 and CD59) with different distribution on hematopoietic and non-hematopoietic tumor cell lines.

P. Speiser, J. Sedlák, M. Turzová, 1992, Neoplasma.

Cell surface labeling of proteins and glycoproteins of some human cultured lymphoid cells.

O. Haas, E. Nacheva, P. Fischer, 1980, Neoplasma.

Biochemical and immunological phenotype alterations in human monoblastoid cell line U-937 induced by physiological (interferon-alpha, retinoic acid) and nonphysiological (phorbol ester) inducers.

J. Sedlák, J. Duraj, M. Sulíková, 1990, Neoplasma.

The protein kinase C inhibitor H7 blocks phosphorylation of stathmin during TPA-induced growth inhibition of human pre-B leukemia REH6 cells.

A. Sobel, J. Sedlák, J. Koppel, 1995, Leukemia research.

Administration of isothiocyanate (E-4IB) and cisplatin leads to altered signalling and lysosomal export in human ovarian carcinoma sensitive- and cisplatin-resistant cells.

J. Chovancová, J. Jakubikova, J. Sedlák, 2009, Neoplasma.

Modulation of EGF receptor and CD15 (Lewisx) antigen on the cell surface of breast carcinoma cell lines induced by cytokines, retinoic acid, 12-O-tetradecanoylphorbol 13-acetate and 1,25(OH)2-vitamin D3.

P. Speiser, J. Sedlák, J. Duraj, 1994, Chemotherapy.

Hunakova L, Sedlakova O, Cholujova D, Gronesova P, Duraj J, Sedlak J.. Modulation of markers associated with aggressive phenotype in MDA-MB-231 breast carcinoma cells by sulforaphane. Neoplasma 56: 548-556

D. Cholujová, J. Sedlák, J. Duraj, 2009 .

The E. coli recA gene can restore the defect in mutagenesis of the pso4-1 mutant of S. cerevisiae.

M. S. Benfato, J. Henriques, V. Vlčková, 1994, Mutation research.

Expression of the Escherichia coli recA gene in the yeast Saccharomyces cerevisiae.

K. Kleibl, M. Piršel, J. Brozmanová, 1991, Biochimie.

Diverse resveratrol sensitization to apoptosis induced by anticancer drugs in sensitive and resistant leukemia cells.

J. Sedlák, J. Bodo, J. Duraj, 2006, Neoplasma.

Radiation-induced apoptosis and cell cycle alterations in human carcinoma cell lines with different radiosensitivities.

J. Chovancová, J. Sedlák, E. Bolješíková, 2000, Neoplasma.

Modulation of leukosialin (sialophorin, CD43 antigen) on the cell surface of human hematopoietic cell lines induced by cytokins, retinoic acid and 1,25(OH)2-vitamin D3.

P. Speiser, J. Sedlák, M. Turzová, 1993, Neoplasma (Bratislava).

Angiogenesis inhibitor TNP-470: cytotoxic effects on human neoplastic cell lines.

J. Chovancová, J. Jakubikova, J. Sedlák, 1999, Neoplasma.

PSC 833 modulation of multidrug resistance to paclitaxel in cultured human ovarian carcinoma cells leads to apoptosis.

J. Chovancová, J. Sedlák, J. Bies, 2002, Anticancer research.

Human multidrug-resistant (MRP,p190) myeloid leukemia HL-60/ADR cells in vitro: resistance to the mevalonate pathway inhibitor lovastatin.

J. Chovancová, J. Sedlák, J. Duraj, 1997, Neoplasma.

Cell surface immunophenotype and gelatinase activity of the human breast carcinoma cell line (MCF-7/6) with functionally defective E-cadherin.

V. Castronovo, J. Sedlák, P. Hlavčák, 1999, Neoplasma.

PSC 833 induces apoptosis in drug-sensitive human leukemia cell line and modulates resistance to paclitaxel in its multidrug-resistant variant.

J. Sedlák, J. Bies, J. Duraj, 2000, Anticancer Research.